Cargando…
Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients
Lung transplant recipients have an increased risk for severe coronavirus disease 2019 (COVID-19) due to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A third dose of a SARS-CoV-2 vaccine has been recommended for all solid organ transplant recipients, but data from lung...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978449/ https://www.ncbi.nlm.nih.gov/pubmed/35390480 http://dx.doi.org/10.1016/j.trim.2022.101599 |